DAX24.254 +0,2%ESt505.391 +0,2%Top 10 Crypto16,17 +1,7%Dow44.633 -0,5%Nas21.098 -0,4%Bitcoin102.418 +0,3%Euro1,1536 -0,1%Öl71,81 -1,3%Gold3.328 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Novo Nordisk A3EU6F Heidelberger Druckmaschinen 731400 NVIDIA 918422 Rheinmetall 703000 Mercedes-Benz Group (ex Daimler) 710000 PayPal A14R7U RENK RENK73 BASF BASF11 Lufthansa 823212 BYD A0M4W9 DroneShield A2DMAA Deutsche Bank 514000 Tesla A1CX3T Volkswagen (VW) vz. 766403 Commerzbank CBK100
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Vor Fed-Zinsentscheid: DAX wenig bewegt -- Mercedes-Benz passt nach schwachem Quartal Prognose an -- D-Wave, DroneShield, Microsoft, Novo Nordisk, BYD, Porsche, adidas, BASF, Rüstungswerte im Fokus
Top News
UBS AG veröffentlicht Investment-Empfehlung: adidas-Aktie mit Buy UBS AG veröffentlicht Investment-Empfehlung: adidas-Aktie mit Buy
Siemens Healthineers-Analyse: Outperform-Bewertung für Siemens Healthineers-Aktie von Bernstein Research Siemens Healthineers-Analyse: Outperform-Bewertung für Siemens Healthineers-Aktie von Bernstein Research
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Anixa Biosciences Aktie

Handeln
Aktien-Sparplan anlegen
2,64 EUR -0,18 EUR -6,38 %
MUN
3,10 USD -0,16 USD -4,91 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.86,37 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N6ZF

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS03528H1095

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolANIX

Anixa Biosciences Aktien News

DatumMeistgelesen
PR NewswireAnixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
PR NewswireAnixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
PR NewswireAnixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024
PR NewswireAnixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
PR NewswireAnixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development
PR NewswireAnixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
PR NewswireAnixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
finanzen.netAnixa Biosciences hat Bilanz für das abgelaufene Quartal gezogen
PR NewswireAnixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
PR NewswireAnixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PR NewswireAnixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
BenzingaAnixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying
PR NewswireAnixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
PR NewswireAnixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
PR NewswireAnixa Biosciences Announces $5 Million Share Repurchase Program
PR NewswireAnixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
finanzen.netAnixa Biosciences stellte Zahlen zum jüngsten Quartal vor
PR NewswireAnixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
PR NewswireAnixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
PR NewswireAnixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
PR NewswireAnixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
PR NewswireAnixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
PR NewswireAnixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
PR NewswireAnixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
PR NewswireAnixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
PR NewswireAnixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
PR NewswireAnixa Biosciences to Present at Biotech Showcase 2024
PR NewswireAnixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
PR NewswireAnixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
PR NewswireAnixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
PR NewswireAnixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference
PR NewswireAnixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board
PR NewswireAnixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
PR NewswireAnixa Biosciences Establishes Cancer Business Advisory Board
PR NewswireAnixa Biosciences to Participate in September Investor Conferences
PR NewswireAnixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences News

Anixa Biosciences News: auf dieser Seite finden Sie alle Anixa Biosciences News und Nachrichten zur Anixa Biosciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Anixa Biosciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Anixa Biosciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.